Aptus Capital Advisors’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
Aptus Capital Advisors's PTEN Position: Q3 2026 in Review
Aptus Capital Advisors reduced its Patterson-UTI (PTEN) stake by 37% in Q3 2026, selling an estimated $93.8K and leaving 14,444 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #1153.
Aptus Capital Advisors first reported a position in PTEN in Q1 2022 and has held it in 10 quarters since. The position peaked at $1.02M in Q1 2022. 443 funds tracked by Wall St. Rank hold PTEN as of Q3 2026.
- Aptus Capital Advisors held 14,444 shares of Patterson-UTI worth $158K as of Q3 2026.
- Aptus Capital Advisors sold 8,542 Patterson-UTI shares in Q3 2026, an estimated $93.8K.
- Patterson-UTI made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q3 2026, its #1153 holding.
- Aptus Capital Advisors first reported a position in Patterson-UTI in Q1 2022 and has held it in 10 quarters since.
- Aptus Capital Advisors's Patterson-UTI position peaked at $1.02M in Q1 2022.
- 443 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2026.
Based on Aptus Capital Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.